The U.S. Food and Drug Administration (FDA) has given Tr1x the green light to launch a first-in-human clinical trial of TRX319, a cell therapy candidate designed to restore immune balance […]
The post Tr1x gets OK for first-in-human trial of TRX319 for progressive MS appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com